Auditory Brainstem Implant (ABI) in Children With No Cochleae or Auditory Nerves

Recruiting N/A Interventional Study
Hearing Loss, Bilateral (Causes Other Than Tumors)
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 Months – 21
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
20 (estimated)
Sponsor
NYU Langone Health · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This study is a feasibility study of the Nucleus 24 ABI in children without NF2. It will be conducted as a repeated-measures, single subject experiment in order to accommodate the known variability in cochlear implant clinical results. Data obtained in the course of this study will be compared with the existing published outcome data from children with normal hearing and with cochlear implants (CI…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Group 1: Prelinguistic hearing loss (birth-5 years; age at implantation of ABI 18 months-5 years) • Pre-linguistic hearing loss (birth-5 yrs.; age at ABI 18 months-5yrs) with both: * MRI +/- CT evidence of one of the following: * Cochlear nerve deficiency * Cochlear aplas…
Contacts

William Shapiro

212-263-3311

William.Shapiro@nyulangone.org

CONTACT

Ashley Feng

Ashley.Feng@nyulangone.org

CONTACT